Grit Bio
沙砾生物GRIT Biotechnology是一家聚焦世界尖端生物科技，专注于肿瘤免疫治疗领域的高科技创新企业。
China · Founded 2019 · $75.3M raised
- Founded
- 2019
- Website
- grit-bio.com
- Total Funding
- $75.3M
- Last Round
- $60.0M Series BSep 2023
- Rounds
- 2
About
Clinical-stage Chinese biotech developing tumor-infiltrating lymphocyte therapy for cancers.
Summary
Grit Bio is a Biotech company based in China, founded in 2019. It has raised $75.3M in total across 2 rounds, most recently a $60.0M Series B round in Sep 2023. Investors include CICC, Yuanhe Capital and B Capital Group.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Sep 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/grit-bio"><img src="https://indexed.vc/api/badge/company/grit-bio" alt="Grit Bio on Indexed.vc" width="260" height="76" /></a>